INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY

Merits and demerits of six ways of an assessment of an intermediate precision (IP) for validation of analytical methods are considered. It is established that only four of them can be recommended for IP assessment, and three - with restrictions Recommendations about use of the considered ways of an...

Full description

Saved in:
Bibliographic Details
Main Author: N. A. Epshtein
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/229
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395880064450560
author N. A. Epshtein
author_facet N. A. Epshtein
author_sort N. A. Epshtein
collection DOAJ
description Merits and demerits of six ways of an assessment of an intermediate precision (IP) for validation of analytical methods are considered. It is established that only four of them can be recommended for IP assessment, and three - with restrictions Recommendations about use of the considered ways of an assessment of IP are made. It is shown that use of the most widely applied way of an assessment of intermediate precision - on a relative standard deviation of set of results of chemists, can lead to receiving a wrong conclusion about an IP of a method. It is offered the new (most universal) way of an assessment of an intermediate precision, that has perspective of application in pharmacy.
format Article
id doaj-art-333fc57d575b49e6ace063e809537896
institution Kabale University
issn 2305-2066
2658-5049
language Russian
publishDate 2019-01-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-333fc57d575b49e6ace063e8095378962025-08-20T03:39:29ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-01-0101106117229INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACYN. A. Epshtein0Autonomous Incorporation «STADAPharmdevelopment», JSC «NIZHPHARM»Merits and demerits of six ways of an assessment of an intermediate precision (IP) for validation of analytical methods are considered. It is established that only four of them can be recommended for IP assessment, and three - with restrictions Recommendations about use of the considered ways of an assessment of IP are made. It is shown that use of the most widely applied way of an assessment of intermediate precision - on a relative standard deviation of set of results of chemists, can lead to receiving a wrong conclusion about an IP of a method. It is offered the new (most universal) way of an assessment of an intermediate precision, that has perspective of application in pharmacy.https://www.pharmjournal.ru/jour/article/view/229validationintermediate precisionintra-laboratory precisionwithin-laboratory precisionwithin-laboratory reproducibilityruggedness
spellingShingle N. A. Epshtein
INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
Разработка и регистрация лекарственных средств
validation
intermediate precision
intra-laboratory precision
within-laboratory precision
within-laboratory reproducibility
ruggedness
title INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
title_full INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
title_fullStr INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
title_full_unstemmed INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
title_short INTERMEDIATE PRECISION DETERMINATION AT VALIDATION OF METHODS IN PHARMACY
title_sort intermediate precision determination at validation of methods in pharmacy
topic validation
intermediate precision
intra-laboratory precision
within-laboratory precision
within-laboratory reproducibility
ruggedness
url https://www.pharmjournal.ru/jour/article/view/229
work_keys_str_mv AT naepshtein intermediateprecisiondeterminationatvalidationofmethodsinpharmacy